{"id":3949,"date":"2014-07-02T09:41:21","date_gmt":"2014-07-02T09:41:21","guid":{"rendered":"https:\/\/jamieson.local\/deals\/sauflon-pharmaceuticals\/"},"modified":"2023-04-24T14:12:02","modified_gmt":"2023-04-24T14:12:02","slug":"sauflon-pharmaceuticals","status":"publish","type":"deals","link":"https:\/\/jamiesoncf.com\/nl\/deals\/sauflon-pharmaceuticals\/","title":{"rendered":"Sauflon Pharmaceuticals"},"content":{"rendered":"

Jamieson Corporate Finance provided advice to Hollyport Capital in relation to the sale of its shareholding in Sauflon Pharmaceuticals to CooperVision in a transaction valued at approximately $1.2bn.\u00a0 As a result of the sale, Hollyport will realise a return of over 60 times initial investment, an IRR in excess of 80%.<\/p>\n

Sauflon is a specialist manufacturer of contact lenses, with annual sales in excess of \u00a3100m.\u00a0 Based in London, it has three state-of-the-art manufacturing plants, sales offices in over 10 countries, and products sold in over 50 countries.<\/p>\n

In the seven years since Hollyport invested, Sauflon has established and expanded new production facilities in Hungary and launched a full suite of Silicon Hydrogel contact lenses, increasing turnover at a compound rate of 20% per annum.\u00a0 The transaction will give CooperVision the world\u2019s most comprehensive portfolio of daily disposable lenses.\u00a0 The acquisition is subject to approval by the German competition authorities.<\/p>\n

\u201cThe team at Jamieson have provided us with valuable advice over the past 8 months and I would like to thank them for doing an excellent job in facilitating the transaction.\u201d<\/p>\n

John Carter, CEO Hollyport<\/span><\/em><\/p><\/blockquote>\n

Ian Jamieson<\/a>, John Greenland<\/a> and David Kirkpatrick<\/a> of Jamieson Corporate Finance advised Hollyport Capital.<\/p>\n","protected":false},"featured_media":3950,"template":"","deal-size":[3],"deal-location":[15],"deal-sector":[85],"deal-service":[100],"class_list":["post-3949","deals","type-deals","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"\nSauflon Pharmaceuticals – Jamieson<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/jamiesoncf.com\/nl\/deals\/sauflon-pharmaceuticals\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sauflon Pharmaceuticals – Jamieson\" \/>\n<meta property=\"og:description\" content=\"Jamieson Corporate Finance provided advice to Hollyport Capital in relation to the sale of its shareholding in Sauflon Pharmaceuticals to CooperVision in a transaction valued at approximately $1.2bn.\u00a0 As a result of the sale, Hollyport will realise a return of over 60 times initial investment, an IRR in excess of 80%. Sauflon is a specialist […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/jamiesoncf.com\/nl\/deals\/sauflon-pharmaceuticals\/\" \/>\n<meta property=\"og:site_name\" content=\"Jamieson\" \/>\n<meta property=\"article:modified_time\" content=\"2023-04-24T14:12:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/jamiesoncf.com\/wp-content\/uploads\/2020\/03\/deals-sauflon.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"468\" \/>\n\t<meta property=\"og:image:height\" content=\"468\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/jamiesoncf.com\\\/nl\\\/deals\\\/sauflon-pharmaceuticals\\\/\",\"url\":\"https:\\\/\\\/jamiesoncf.com\\\/nl\\\/deals\\\/sauflon-pharmaceuticals\\\/\",\"name\":\"Sauflon Pharmaceuticals – Jamieson\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/jamiesoncf.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/jamiesoncf.com\\\/nl\\\/deals\\\/sauflon-pharmaceuticals\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/jamiesoncf.com\\\/nl\\\/deals\\\/sauflon-pharmaceuticals\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/jamiesoncf.com\\\/wp-content\\\/uploads\\\/2020\\\/03\\\/deals-sauflon.jpg\",\"datePublished\":\"2014-07-02T09:41:21+00:00\",\"dateModified\":\"2023-04-24T14:12:02+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/jamiesoncf.com\\\/nl\\\/deals\\\/sauflon-pharmaceuticals\\\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/jamiesoncf.com\\\/nl\\\/deals\\\/sauflon-pharmaceuticals\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/jamiesoncf.com\\\/nl\\\/deals\\\/sauflon-pharmaceuticals\\\/#primaryimage\",\"url\":\"https:\\\/\\\/jamiesoncf.com\\\/wp-content\\\/uploads\\\/2020\\\/03\\\/deals-sauflon.jpg\",\"contentUrl\":\"https:\\\/\\\/jamiesoncf.com\\\/wp-content\\\/uploads\\\/2020\\\/03\\\/deals-sauflon.jpg\",\"width\":468,\"height\":468},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/jamiesoncf.com\\\/nl\\\/deals\\\/sauflon-pharmaceuticals\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/jamiesoncf.com\\\/nl\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Deals\",\"item\":\"https:\\\/\\\/jamiesoncf.com\\\/deals\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Sauflon Pharmaceuticals\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/jamiesoncf.com\\\/#website\",\"url\":\"https:\\\/\\\/jamiesoncf.com\\\/\",\"name\":\"Jamieson\",\"description\":\"Wij adviseren management teams hoe zij private equity transacties het beste kunnen aanvliegen en structureren\",\"publisher\":{\"@id\":\"https:\\\/\\\/jamiesoncf.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/jamiesoncf.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/jamiesoncf.com\\\/#organization\",\"name\":\"Jamieson Corporate Finance\",\"url\":\"https:\\\/\\\/jamiesoncf.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\\\/\\\/jamiesoncf.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/jamiesoncf.com\\\/wp-content\\\/uploads\\\/2020\\\/01\\\/screenshot-1.png\",\"contentUrl\":\"https:\\\/\\\/jamiesoncf.com\\\/wp-content\\\/uploads\\\/2020\\\/01\\\/screenshot-1.png\",\"width\":1200,\"height\":900,\"caption\":\"Jamieson Corporate Finance\"},\"image\":{\"@id\":\"https:\\\/\\\/jamiesoncf.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/jamieson-corporate-finance\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sauflon Pharmaceuticals – Jamieson","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/jamiesoncf.com\/nl\/deals\/sauflon-pharmaceuticals\/","og_locale":"nl_NL","og_type":"article","og_title":"Sauflon Pharmaceuticals – Jamieson","og_description":"Jamieson Corporate Finance provided advice to Hollyport Capital in relation to the sale of its shareholding in Sauflon Pharmaceuticals to CooperVision in a transaction valued at approximately $1.2bn.\u00a0 As a result of the sale, Hollyport will realise a return of over 60 times initial investment, an IRR in excess of 80%. Sauflon is a specialist […]","og_url":"https:\/\/jamiesoncf.com\/nl\/deals\/sauflon-pharmaceuticals\/","og_site_name":"Jamieson","article_modified_time":"2023-04-24T14:12:02+00:00","og_image":[{"width":468,"height":468,"url":"https:\/\/jamiesoncf.com\/wp-content\/uploads\/2020\/03\/deals-sauflon.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Geschatte leestijd":"1 minuut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/jamiesoncf.com\/nl\/deals\/sauflon-pharmaceuticals\/","url":"https:\/\/jamiesoncf.com\/nl\/deals\/sauflon-pharmaceuticals\/","name":"Sauflon Pharmaceuticals – Jamieson","isPartOf":{"@id":"https:\/\/jamiesoncf.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/jamiesoncf.com\/nl\/deals\/sauflon-pharmaceuticals\/#primaryimage"},"image":{"@id":"https:\/\/jamiesoncf.com\/nl\/deals\/sauflon-pharmaceuticals\/#primaryimage"},"thumbnailUrl":"https:\/\/jamiesoncf.com\/wp-content\/uploads\/2020\/03\/deals-sauflon.jpg","datePublished":"2014-07-02T09:41:21+00:00","dateModified":"2023-04-24T14:12:02+00:00","breadcrumb":{"@id":"https:\/\/jamiesoncf.com\/nl\/deals\/sauflon-pharmaceuticals\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/jamiesoncf.com\/nl\/deals\/sauflon-pharmaceuticals\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/jamiesoncf.com\/nl\/deals\/sauflon-pharmaceuticals\/#primaryimage","url":"https:\/\/jamiesoncf.com\/wp-content\/uploads\/2020\/03\/deals-sauflon.jpg","contentUrl":"https:\/\/jamiesoncf.com\/wp-content\/uploads\/2020\/03\/deals-sauflon.jpg","width":468,"height":468},{"@type":"BreadcrumbList","@id":"https:\/\/jamiesoncf.com\/nl\/deals\/sauflon-pharmaceuticals\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/jamiesoncf.com\/nl\/"},{"@type":"ListItem","position":2,"name":"Deals","item":"https:\/\/jamiesoncf.com\/deals\/"},{"@type":"ListItem","position":3,"name":"Sauflon Pharmaceuticals"}]},{"@type":"WebSite","@id":"https:\/\/jamiesoncf.com\/#website","url":"https:\/\/jamiesoncf.com\/","name":"Jamieson","description":"Wij adviseren management teams hoe zij private equity transacties het beste kunnen aanvliegen en structureren","publisher":{"@id":"https:\/\/jamiesoncf.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/jamiesoncf.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/jamiesoncf.com\/#organization","name":"Jamieson Corporate Finance","url":"https:\/\/jamiesoncf.com\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/jamiesoncf.com\/#\/schema\/logo\/image\/","url":"https:\/\/jamiesoncf.com\/wp-content\/uploads\/2020\/01\/screenshot-1.png","contentUrl":"https:\/\/jamiesoncf.com\/wp-content\/uploads\/2020\/01\/screenshot-1.png","width":1200,"height":900,"caption":"Jamieson Corporate Finance"},"image":{"@id":"https:\/\/jamiesoncf.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/jamieson-corporate-finance\/"]}]}},"_links":{"self":[{"href":"https:\/\/jamiesoncf.com\/nl\/wp-json\/wp\/v2\/deals\/3949","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jamiesoncf.com\/nl\/wp-json\/wp\/v2\/deals"}],"about":[{"href":"https:\/\/jamiesoncf.com\/nl\/wp-json\/wp\/v2\/types\/deals"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/jamiesoncf.com\/nl\/wp-json\/wp\/v2\/media\/3950"}],"wp:attachment":[{"href":"https:\/\/jamiesoncf.com\/nl\/wp-json\/wp\/v2\/media?parent=3949"}],"wp:term":[{"taxonomy":"deal-size","embeddable":true,"href":"https:\/\/jamiesoncf.com\/nl\/wp-json\/wp\/v2\/deal-size?post=3949"},{"taxonomy":"deal-location","embeddable":true,"href":"https:\/\/jamiesoncf.com\/nl\/wp-json\/wp\/v2\/deal-location?post=3949"},{"taxonomy":"deal-sector","embeddable":true,"href":"https:\/\/jamiesoncf.com\/nl\/wp-json\/wp\/v2\/deal-sector?post=3949"},{"taxonomy":"deal-service","embeddable":true,"href":"https:\/\/jamiesoncf.com\/nl\/wp-json\/wp\/v2\/deal-service?post=3949"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}